Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction

Journal of Cardiovascular Magnetic Resonance

Volumn 17, Issue 1, 2015, Pages

  Eitel, Ingo ^a   Poss J ^a   Jobs, A ^a   Eitel, C ^a   De Waha, S ^a   Barkhausen, J ^b   Desch, S ^a   Thiele, H ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Cardiovascular magnetic resonance; Left ventricular ejection fraction; Left ventricular global function index; Myocardial infarction; Prognosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRASUGREL; ANTITHROMBOCYTIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG DOSAGE FORM COMPARISON; FEMALE; FUNCTIONAL ASSESSMENT; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEART MUSCLE REPERFUSION; HUMAN; INCIDENCE; INTRAMYOCARDIAL HEMORRHAGE; LEFT VENTRICULAR PERFORMANCE INDEX; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MORTALITY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE SCANNER; OPEN STUDY; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SALVAGE THERAPY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYMPTOM; TRANSLUMINAL CORONARY ANGIOPLASTY; CLINICAL TRIAL; GERMANY; HEART CONTRACTION; HEART STROKE VOLUME; MIDDLE AGED; MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; FEMALE; GERMANY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84937040607     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-015-0161-x     Document Type: Article

References (22)

1. Hill JA, Olson EN. Cardiac plasticity. The N Engl J Med. 2008;358:1370-80.
2. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331-336.
3. Rouleau JL, Talajic M, Sussex B, Potvin L, Warnica W, Davies RF, et al. Myocardial infarction patients in the 1990s - their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol. 1996;27:1119-27.
4. Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). EurHeart J. 2012;33:2569-619.
5. Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, et al. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovascular Imaging. 2008;1:582-91.
6. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141:334-41.
7. Mewton N, Opdahl A, Choi EY, Almeida AL, Kawel N, Wu CO, et al. Left ventricular global function index by magnetic resonance imaging - a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the multi-ethnic study of atherosclerosis. Hypertension. 2013;61:770.
8. Reinstadler SJ, Klug G, Feistritzer HJ, Mayr A, Kofler M, Aschauer A. Left ventricular global function index: Relation with infarct characteristics and left ventricular ejection fraction after STEMI. Int J Cardiol. 2014;175:579-81.
9. Kim HW, Farzaneh-Far A, Kim RJ. Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol. 2009;55:1-16.
10. Thiele H, Wohrle J, Neuhaus P, Brosteanu O, Sick P, Prondzinsky R, et al. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial. Am Heart J. 2010;159:547-54.
11. Thiele H, Wohrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B, et al. Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. Lancet. 2012;379:923-31.
12. Eitel I, Wohrle J, Suenkel H, Meissner J, Kerber S, Lauer B, et al. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. J Am Coll Cardiol. 2013;61:1447-54.
13. Eitel I, Desch S, Fuernau G, Hildebrand L, Gutberlet M, Schuler G, et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol. 2010;55:2470-9.
14. Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol. 2006;47:1641-5.
15. Desch S, Engelhardt H, Meissner J, Eitel I, Sareban M, Fuernau G, et al. Reliability of myocardial salvage assessment by cardiac magnetic resonance imaging in acute reperfused myocardial infarction. Int J Cardiovasc Imaging. 2012;28:263-72.
16. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-45.
17. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101:2981-8.
18. Nijveldt R, Hofman MB, Hirsch A, Beek AM, Umans VA, Algra PR, et al. Assessment of microvascular obstruction and prediction of short-term remodeling after acute myocardial infarction: cardiac MR imaging study. Radiology. 2009;250:363-70.
19. Schulz-Menger J, Gross M, Messroghli D, Uhlich F, Dietz R, Friedrich MG. Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol. 2003;42:513-8.
20. Eitel I, de Waha S, Wöhrle J, Fuernau G, Lurz P, Pauschinger M, et al. Comprehensive Prognosis Assessment by CMR Imaging After ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2014;64:1217-26.
21. Fernández-Jiménez R, Sánchez-González J, Agüero J, García-Prieto J, López-Martín GJ, García-Ruiz JM, et al. Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization. J Am Coll Cardiol. 2015;65:315-23.
22. Wince WB, Kim RJ. Molecular imaging: T2-weighted CMRof the area at risk - a risky business? Nat Rev Cardiol. 2010;7:547-9.